Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026)
Immix Biopharma (IMMX) reported Amortizatization of Intangibles of $39189.0 for Q1 2026, up 86.37% on a YoY basis from $21027.0 in Q1 2025, and up 1.74% sequentially from $38517.0 in Q4 2025.
Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 4 years of Amortizatization of Intangibles data on file, last reported at $39189.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 86.37% year-over-year to $39189.0; the trailing twelve-month figure through Mar 2026 stood at $136916.0 (up 65.69% YoY), and the FY2025 full-year result was $118754.0, up 44.04% from the prior year.
- Amortizatization of Intangibles improved to $39189.0 in Q1 2026, from $38517.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $39189.0 in Q1 2026 to a low of $20416.0 in Q2 2024.
- A 3-year average of $26710.0 and a median of $21027.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles climbed 0.9% in 2025 and surged 86.37% in 2026, its largest moves.
- Tracing IMMX's Amortizatization of Intangibles over 3 years: stood at $20734.0 in 2024, then surged by 85.77% to $38517.0 in 2025, then increased by 1.74% to $39189.0 in 2026.
- Business Quant data shows IMMX's Amortizatization of Intangibles at $39189.0 in Q1 2026, $38517.0 in Q4 2025, and $37869.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Immix Biopharma | 473.68 Mn | 473.68 Mn | - | 39,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,189.00 |
| Mar 31, 2026 | 39,189.00 |
| Dec 31, 2025 | 38,517.00 |
| Dec 31, 2025 | 38,517.00 |
| Sep 30, 2025 | 37,869.00 |
| Sep 30, 2025 | 37,869.00 |
| Jun 30, 2025 | 21,341.00 |
| Jun 30, 2025 | 21,341.00 |
| Mar 31, 2025 | 21,027.00 |
| Mar 31, 2025 | 21,027.00 |
| Dec 31, 2024 | 20,734.00 |
| Dec 31, 2024 | 20,734.00 |
| Sep 30, 2024 | 20,457.00 |
| Sep 30, 2024 | 20,457.00 |
| Jun 30, 2024 | 20,416.00 |
| Jun 30, 2024 | 20,416.00 |
| Mar 31, 2024 | 20,840.00 |
| Mar 31, 2024 | 20,840.00 |
| Dec 31, 2021 | 16,619.00 |
| Dec 31, 2021 | 16,619.00 |